Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review-Reference-Cited by-同舟云学术

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review

Published:2021-12-08 Issue: Volume: Page:
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Moik Florian¹²^ORCID,Colling Meaghan¹³,Mahé Isabelle⁴⁵⁶,Jara‐Palomares Luis⁷⁸^ORCID,Pabinger Ingrid¹^ORCID,Ay Cihan¹⁹^ORCID

Affiliation:

1. Clinical Division of Haematology and Haemostaseology Department of Medicine I Comprehensive Cancer Center Vienna Medical University of Vienna Vienna Austria

2. Division of Oncology Department of Internal Medicine Medical University of Graz Graz Austria

3. Division of Intramural Research (M.E.C.) National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA

4. Department of Internal Medicine Colombes APHP Hôpital Louis Mourier Université de Paris Paris France

5. Innovative Therapies in Haemostasis Institut National de la Sante et de la Recherche Medicale (INSERM) Université de Paris Paris France

6. F‐CRIN INNOVTE Network Saint Etienne France

7. Respiratory Department Medical Surgical Unit of Respiratory Diseases Hospital Universitario Virgen del Rocio Sevilla Spain

8. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) Instituto de Salud Carlos III Madrid Spain

9. I. M. Sechenov First Moscow State Medical University Moscow Russia

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15599

Reference36 articles.

1. Venous thromboembolism in cancer patients: a population-based cohort study

2. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

3. Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future

4. Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

5. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding Risk in Patients with Cancer;Hämostaseologie;2024-09-03

2. SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023);Clinical and Translational Oncology;2024-08-07

3. Tumorassoziierte Thrombose;Onkologische Welt;2024-07

4. Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy;Bleeding, Thrombosis and Vascular Biology;2024-05-16

5. An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county;Research and Practice in Thrombosis and Haemostasis;2024-05